ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI)
NCT05221372
·
clinicaltrials.gov ↗
RECRUITING
Status
1300
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Liquid Biopsy
Tyrosine Kinase Inhibitor
Sponsor
Erasmus Medical Center